Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment tags : Fast track designation save search
Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma
Published: 2023-09-12 (Crawled : 11:00) - globenewswire.com
AFMD | $5.0 -2.91% -3.0% 96K
|
Health Technology
|
| O: 4.1%
H: 4.71%
C: -1.73%
afm13 allonk fda treatment designation fast track designation
Astria Therapeutics Receives Fast Track Designation for STAR-0215 for the Treatment of Hereditary Angioedema
Published: 2023-07-20 (Crawled : 13:00) - biospace.com/
ATXS | $9.81 0.62% 0.61% 1.5M
|
Manufacturing
|
| O: 0.11%
H: 7.01%
C: 4.67%
star-0215 treatment designation therapeutics fast track designation
Karyopharm Receives FDA Fast Track Designation for Selinexor for the Treatment of Myelofibrosis
Published: 2023-07-17 (Crawled : 20:00) - prnewswire.com
KPTI | $1.12 -4.27% -4.46% 770K
|
Health Technology
|
| O: 18.95%
H: 0.0%
C: -18.13%
fda treatment designation fast track designation
Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria
Published: 2023-07-11 (Crawled : 11:00) - globenewswire.com
SYBX | $1.89 1.07% 1.06% 22K
|
Health Technology
|
| O: 5.0%
H: 7.6%
C: 0.47%
synb1934 fda granted treatment designation phenylketonuria fast track designation
KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY
Published: 2023-07-06 (Crawled : 11:00) - prnewswire.com
KZIA | $0.399 6.12% 5.76% 120K
|
Health Technology
|
| O: 7.69%
H: 1.59%
C: -15.08%
fda paxalisib treatment designation tumor therapy fast track designation
Genprex Receives U.S. FDA Fast Track Designation for REQORSA® Immunogene Therapy in Combination with Tecentriq® for the Treatment of Small Cell Lung Cancer
Published: 2023-06-28 (Crawled : 14:00) - biospace.com/
AZNCF | News | $136.2 -4.19% 1.7K
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: -2.36%
GNPX | $2.15 0.94% 0.93% 19K
|
Health Technology
|
| O: 14.85%
H: 1.18%
C: -7.27%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: -0.29%
H: 0.13%
C: -0.7%
reqorsa fda lung cancer cell treatment designation therapy fast track designation
SAR’579 / IPH6101 Receives FDA Fast Track Designation in the US for the Treatment of Hematological Malignancies
Published: 2023-06-08 (Crawled : 07:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 7.42%
H: 1.2%
C: 1.2%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.37%
H: 0.94%
C: 0.78%
IPHA | $2.28 -6.56% -7.02% 9.5K
|
Health Technology
|
| O: 8.31%
H: 4.91%
C: 1.84%
iph6101 fda treatment designation fast track designation
Inhibrx Granted Fast Track Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency
Published: 2023-05-30 (Crawled : 17:00) - biospace.com/
INBX | $34.15 -0.5% -0.5% 390K
|
Health Technology
|
| O: -0.08%
H: 1.94%
C: -2.61%
inbrx-101 granted treatment designation fast track designation
SAB Biotherapeutics to Present Novel Human IgG Platform with Positive Data and Breakthrough Therapy and Fast-Track Designations for Influenza Treatment at BIO 2023 International Convention
Published: 2023-05-30 (Crawled : 13:00) - globenewswire.com
SABS | $4.64 8.16% 7.54% 1.7K
|
|
| O: -1.19%
H: 4.66%
C: 4.08%
positive international influenza treatment therapy platform fast track designation
Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for Isaralgagene Civaparvovec for the Treatment of Fabry Disease
Published: 2023-05-22 (Crawled : 13:00) - biospace.com/
SGMO | News | $0.5151 0.7% 0.7% 1.3M
|
Health Technology
|
| O: 2.33%
H: 3.79%
C: 3.03%
fda disease treatment designation therapeutics fast track designation
Atea Pharmaceuticals Announces U.S. FDA Fast Track Designation Granted to Bemnifosbuvir, an Investigational Oral Antiviral, for the Treatment of COVID-19
Published: 2023-04-25 (Crawled : 11:00) - ir.ateapharma.com
AVIR | $3.68 -1.08% -1.09% 350K
|
Health Technology
|
| O: 0.62%
H: 2.74%
C: 1.86%
covid-19 fda granted treatment pharmaceuticals designation fast track designation
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Published: 2023-04-24 (Crawled : 21:00) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: 0.74%
H: 3.08%
C: -3.81%
LNTH | $63.1 -1.11% -1.13% 650K
|
Health Technology
|
| O: 0.02%
H: 0.86%
C: 0.63%
pnt2002 fda cancer treatment biopharma designation grants fast track designation
Avidity Biosciences Granted FDA Fast Track Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy Mutations Amenable to Exon 44 Skipping
Published: 2023-04-24 (Crawled : 17:00) - biospace.com/
RNA | News M | $24.17 6.34% 5.96% 910K
|
Health Technology
|
| O: 0.49%
H: 3.67%
C: 2.8%
fda granted treatment designation duchenne fast track designation
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for 177Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Published: 2023-04-24 (Crawled : 12:00) - biospace.com/
PNT | $13.68 2.63% 0.15% 0
|
|
| O: 0.74%
H: 3.08%
C: -3.81%
LNTH | $63.1 -1.11% -1.13% 650K
|
Health Technology
|
| O: 0.02%
H: 0.86%
C: 0.63%
pnt2002 fda cancer treatment biopharma designation grants fast track designation
REGENXBIO Receives FDA Fast Track Designation for RGX-202, a Novel Gene Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy
Published: 2023-04-11 (Crawled : 13:20) - biospace.com/
RGNX | $15.68 -0.06% -0.06% 440K
|
Health Technology
|
| O: 1.68%
H: 3.7%
C: 0.91%
rgx-202 fda candidate treatment designation duchenne therapy fast track designation
Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus
Published: 2023-04-06 (Crawled : 14:00) - biospace.com/
ENTA | $13.44 0.9% 0.89% 67K
|
Health Technology
|
| O: 1.3%
H: 2.71%
C: 2.21%
edp-323 fda respiratory treatment pharmaceuticals designation virus fast track designation
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome
Published: 2023-01-26 (Crawled : 13:00) - biospace.com/
SYRS | $4.99 9.91% 9.02% 150K
|
Health Technology
|
| O: 2.93%
H: 2.41%
C: -3.28%
treatment fda designation fast track designation
Avidity Biosciences Granted FDA Fast Track Designation for AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy
Published: 2023-01-18 (Crawled : 18:00) - biospace.com/
RNA | News M | $24.17 6.34% 5.96% 910K
|
Health Technology
|
| O: 0.36%
H: 3.62%
C: -1.59%
treatment fda designation granted fast track designation
Bicycle Therapeutics Announces FDA Fast Track Designation Granted to BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic Urothelial Cancer
Published: 2023-01-04 (Crawled : 13:00) - biospace.com/
BCYC | $22.54 -3.88% -4.04% 310K
|
Health Technology
|
| O: 4.13%
H: 0.0%
C: -1.41%
bt8009 treatment fda designation granted therapeutics bicycle cancer fast track designation
Moleculin Granted FDA Fast Track Designation of WP1122 for the Treatment of Glioblastoma Multiforme
Published: 2022-12-07 (Crawled : 14:00) - prnewswire.com
MBRX | $4.45 -4.3% -4.49% 17K
|
Health Technology
|
| O: 3.88%
H: 12.69%
C: 11.19%
wp1122 treatment fda designation granted fast track designation glioblastoma
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.